Elicio Therapeutics(ELTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ELTX Elicio Therapeutics

Trading 08-25 10:35:14 EDT

3.08

+0.10

+3.19%

High3.08	Low3.00	Vol74.93K
Open3.00	D1 Closing2.98	Amplitude2.68%
Mkt Cap80.82M	Tradable Cap59.02M	Total Shares26.28M
T/O228.13K	T/O Rate0.39%	Tradable Shares19.19M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ELTX","market":"US","secType":"STK","nameCN":"Elicio Therapeutics","latestPrice":3.075,"timestamp":1787668514252,"preClose":2.98,"halted":0,"volume":74930,"delay":0,"changeRate":0.03187919463087255,"floatShares":19192300,"shares":26281900,"eps":-2.172087,"marketStatus":"Trading","change":0.095,"latestTime":"08-25 10:35:14 EDT","open":3,"high":3.08,"low":3,"amount":228127.577018,"amplitude":0.026846,"askPrice":3.09,"askSize":3690,"bidPrice":3.04,"bidSize":1100,"shortable":3,"etf":0,"ttmEps":-2.172087,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":2.98,"preHourTrading":{"tag":"盘前","latestPrice":3.01,"preClose":2.98,"latestTime":"09:28 EDT","volume":3407,"amount":10523.1719405,"timestamp":1787664481083,"change":0.03,"changeRate":0.010067,"amplitude":0.109664},"postHourTrading":{"tag":"盘后","latestPrice":2.9501,"preClose":2.98,"latestTime":"19:53 EDT","volume":3346,"amount":9882.397,"timestamp":1787615631925,"change":-0.0299,"changeRate":-0.010034,"amplitude":0.010034},"volumeRatio":1.309317,"impliedVol":2.2476,"impliedVolPercentile":0.7809},"requestUrl":"/m/hq/s/ELTX","defaultTab":"news","newsList":[{"id":"2661763202","title":"Elicio Therapeutics to Hold One-on-One Investor Meetings at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2661763202","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661763202?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:02","pubTimestamp":1787572933,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics to hold one-on-one investor meetings at Wells Fargo Healthcare ConferenceElicio Therapeutics will hold one-on-one investor meetings at the Wells Fargo 21st Annual Healthcare Confer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL8JdwkR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BCDF","LU2095319765.USD","SG9999014039.USD","LU0314104364.USD","BK4585","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","SG9999014021.USD","BK4588","IE00BQXX3C00.GBP","BK4007","LU2210149790.SGD","SG9999014013.SGD","LU2210150020.SGD","BK4112","IE00BN0W2T93.GBP","ELTX","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660617464","title":"Elicio Therapeutics Price Target Maintained with a $23.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2660617464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660617464?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:37","pubTimestamp":1787053020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ELTX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659673881","title":"Elicio Therapeutics Q2 EPS $(0.43) Beats $(0.54) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659673881","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659673881?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:18","pubTimestamp":1786652336,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics (NASDAQ:ELTX) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.54) by 20.37 percent. This is a 34.85 percent increase over losses of $(0.66) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61193668/elicio-therapeutics-q2-eps-0-43-beats-0-54-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Elicio Therapeutics Q2 EPS $(0.43) Beats $(0.54) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659416241","title":"Elicio Therapeutics Q2 Net Loss Narrows as R&D Expenses Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2659416241","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659416241?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:09","pubTimestamp":1786651788,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics Q2 net loss narrows as R&D expenses fallOverviewUS biotech firm's Q2 net loss narrowed yr/yr as R&D expenses declinedCompany completed $15 mln financing in July, extending cash run","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A13X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELTX","ARTL","BK4563","BK4139","BK4007","IMNM","CRDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164765","title":"Elicio Therapeutics Q2 Basic EPS USD -0.43","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164765?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:01","pubTimestamp":1786651261,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLXWHNL3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164748","title":"Elicio Therapeutics Q2 Income from Operations USD -10.429 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164748?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:01","pubTimestamp":1786651261,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLXWHNL3C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162812","title":"Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162812","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162812?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:01","pubTimestamp":1786651260,"startTime":"0","endTime":"0","summary":"Following the observation of multiple complete responses, Elicio plans to initiate a Phase 1 combination study of ELI-002 7P plus a RAS small molecule inhibitor with or without an anti-PD-1 inhibitor ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344883/0/en/elicio-therapeutics-reports-second-quarter-2026-financial-results-and-provides-corporate-updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","IDNA","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658354639","title":"Elicio Opens Phase 1 Neoadjuvant ELI-002 7P Trial in Resectable Pancreatic Cancer at MSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2658354639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658354639?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363257,"startTime":"0","endTime":"0","summary":"Elicio opens Phase 1 neoadjuvant ELI-002 7P trial in resectable pancreatic cancer at MSKElicio opened an investigator-initiated Phase 1 neoadjuvant trial of ELI-002 7P in resectable or borderline rese","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLwRkgW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","BK4585","BK4139","SG9999014039.USD","ELTX","SG9999014005.SGD","LU2095319765.USD","BK4588","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","NDAQ","LU2210150020.SGD","LU2210149790.SGD","LU0314104364.USD","IE00BN0W2W23.USD","BCDF","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4007","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658901935","title":"Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant Eli-002 7P for Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2658901935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658901935?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA7RCKB8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658466935","title":"Elicio Therapeutics - Study Expected to Enroll 20 Patients with Resectable or Borderline Resectable Pdac","url":"https://stock-news.laohu8.com/highlight/detail?id=2658466935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658466935?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA7RCKB8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614462","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614462","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657614462?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:00","pubTimestamp":1786096800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ACM Research Inc. Class A                       2Q       .42       BMO. Algonquin Power & Utilities Corp.                2Q       .03   6:30 AM. Alpha Metallurgical Resources Inc.               2Q      (.43)  7:30 AM. Construction Partners Inc. Class A              3Q      1.01       BMO. Kimbell Royalty Partners LP                      2Q       .23   7:00 AM. Park Hotels & Resorts Inc.                        2Q       .25       AMC. Plains All American Pipeline L.P.                2Q       .38   7:30 AM. Plains GP Hldgs LP Class A                      2Q       .46   7:30 AM. Rapid Micro BioSyss Inc. Class A                2Q      (.24)      BMO. Spectrum Brands Hldgs Inc.                       3Q      1.46   6:30 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELVA","AMTM","BWMN","CBLL","EMBC","AIOT","EMA","CIB","CRC","ANIP","DMAC","ACHR","AMR","CTEV","B","ACVA","BTDR","ACH","APEI","BKD","DCGO","ACM","AXSM","ACMR","ASTS","CAMT","ATMU","AAON","ANAB","ARQ","BBIO","DCBO","AQN","DH","CNDT","BZH","CODI","ALMR","UA","BODI","ALC","CNTY","BCSF","CGC","CCAP","CEVA","DCH","CLMT","ELTX","CECO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373074","title":"Elicio Therapeutics Inc Expected to Post a Loss of 54 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373074","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373074?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:16","pubTimestamp":1785755766,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics Inc <ELTX.OQ> expected to post a loss of54cents a share - Earnings PreviewElicio Therapeutics IncELTX.OQELTX.Ois expected to  show no change in quarterly revenue when it reports  r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4400X8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649067460","title":"Elicio Therapeutics Closes $15 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2649067460","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649067460?lang=en_us&edition=fundamental","pubTime":"2026-07-07 05:39","pubTimestamp":1783373991,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics  said late Monday it has closed its registered direct offering under a definitive securities purchase agreement, led by two new fundamental institutional investors and a large existing shareholder, to purchase an aggregate of 4.4 million common shares for gross proceeds of approximately $15 million.Elicio said it intends to use the net proceeds from the offering, along with existing cash, cash equivalents and marketable securities, to fund the planned phase 1 clinical development of ELI-002 7P in metastatic pancreatic ductal adenocarcinoma, and its pipeline and platform, as well as for working capital and general corporate purposes.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679945","title":"Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679945?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:05","pubTimestamp":1783368300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA9ZQ2LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648682171","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2648682171","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648682171?lang=en_us&edition=fundamental","pubTime":"2026-07-03 01:58","pubTimestamp":1783015092,"startTime":"0","endTime":"0","summary":"Idaho Copper  priced its underwritten public offering of stocks and warrants at $4.85 apiece, targeting about $18 million in gross proceeds, it said late Wednesday.The shares began trading on Thursday, down 34% amid intraday trading volume of about 415,000.Elicio Therapeutics'  shares sank 34% after the company said Thursday it priced a registered direct offering of about 4.4 million shares.More than 3.43 million shares of the company traded intraday compared with a daily average of about 1.45 million.Ouster  priced an underwritten public offering of 3.62 million common shares at $55.22 apiece, for expected gross proceeds of about $200 million, the company said Thursday.Shares slumped 18%, with intraday trading volume at about 6.65 million versus a daily average of roughly 4.41 million.Price: 4.10, Change: -2.15, Percent Change: -34.40","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COPR","ELTX","BK4007","BK4139","OUST","BK4157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648068125","title":"U.S. Stocks on the Move-silicom, Blue Owl, Intel","url":"https://stock-news.laohu8.com/highlight/detail?id=2648068125","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648068125?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:19","pubTimestamp":1783009173,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Silicom, Blue Owl, IntelWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL6N4341RA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNDQ","MEI","OWL","RIVN","ARCT","FC","NEXA","NWMX","LINT","INTC","ONTO","HONA","CLRO","DLTR","LHAI","FPS","CVEO","ELTX","LCDL","TMO","SNDC","AU","CWD","HCA","LCIZ","NEM","SNDU","SNXX","WBX","JPMO","KLAC","MRNX","GE","MRNY","SNDG","TER","TERG","MRNA","HSBA.UK","YRD","LCID","OUST","SILC","KLAG","UHS","RVNL","INTW","JPO","SNDK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648168897","title":"Wall Street Set to Open Higher in Thursday Trading; US Adds Only 57,000 Jobs in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2648168897","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648168897?lang=en_us&edition=fundamental","pubTime":"2026-07-02 21:23","pubTimestamp":1782998598,"startTime":"0","endTime":"0","summary":"US stocks look set to open higher in Thursday's trading session as investors parse key employment data released earlier in the morning.Dow Jones Industrial Average futures were up 0.3%, S&P 500 future","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JEPI","QQQY","SPUS",".SPX","USDE","QQQM","SPHQ","GSLC","SDS",".IXIC","VBK","RSPU","DVY","HIBS","TENX","IVV","XLG","ONEQ","SPXS","SQQQ","QLD","ACWI","IYW","TOPT","ELTX","TSPY","NQmain","RSP","VOOG","QDTE","JEPQ","SURG","VTI","SH","YMAX","VTV",".DJI","SPY","ETFT","XLI","LHAI","DDM","PSQ","MYMmain","QID","DJIA","SPXU","BMAY","INLF","XYLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648504129","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2648504129","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648504129?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:32","pubTimestamp":1782991951,"startTime":"0","endTime":"0","summary":"Linkhome  shares were down 31% in Thursday premarket activity, following the previous session's 315% gain after the company announced the acquisition of Mortgage One Group.Eason Technology  stock was down 23%, following the previous session's 141% gain.INLIF  shares were down 23% after its board approved a 1-for-200 share combination of the company's shares.Elicio Therapeutics  stock was down 21% after pricing a registered direct offering of about 4.4 million shares.Franklin Covey  shares were down 18% after the company lowered its fiscal 2026 revenue guidance.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","DXF","FC","BK4123","LHAI","BK4161","INLF","BK4164","ELTX","BK4007","BK4079"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648505782","title":"Elicio Therapeutics announces pricing of $15M registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2648505782","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648505782?lang=en_us&edition=fundamental","pubTime":"2026-07-02 17:30","pubTimestamp":1782984613,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics (ELTX) announced that it has entered into a definitive securities purchase agreement led by two new fundamental institutional i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-announces-pricing-of-15m-registered-direct-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-announces-pricing-of-15m-registered-direct-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648577672","title":"Elicio Therapeutics Prices $15 Million Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2648577672","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648577672?lang=en_us&edition=fundamental","pubTime":"2026-07-02 15:39","pubTimestamp":1782977961,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics  has priced a registered direct offering of about 4.4 million common shares for gross proceeds of about $15 million, the company said Thursday.The offering, led by two new fundamental institutional investors and an existing shareholder, is expected to close on or about July 6, Elicio said.Net proceeds will be used to primarily fund the planned phase 1 clinical development of ELI-002 7P, as well as its pipeline and platform, working capital, and general corporate purposes, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4139","ELTX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.elicio.com","stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":-0.0067},{"period":"3month","weight":-0.7029},{"period":"6month","weight":-0.7286},{"period":"1year","weight":-0.7475},{"period":"ytd","weight":-0.6256}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1014},{"period":"1year","weight":0.1831},{"period":"ytd","weight":0.1196}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.025227},{"month":2,"riseRate":0.2,"avgChangeRate":0.020436},{"month":3,"riseRate":0.5,"avgChangeRate":0.087379},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.052623},{"month":5,"riseRate":0.833333,"avgChangeRate":0.199324},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.268302},{"month":7,"riseRate":0.5,"avgChangeRate":0.002708},{"month":8,"riseRate":0.5,"avgChangeRate":-0.047269},{"month":9,"riseRate":0.6,"avgChangeRate":0.034992},{"month":10,"riseRate":0.2,"avgChangeRate":-0.198973},{"month":11,"riseRate":0.4,"avgChangeRate":-0.034248},{"month":12,"riseRate":0.4,"avgChangeRate":-0.005753}],"exchange":"NASDAQ","name":"Elicio Therapeutics","nameEN":"Elicio Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Elicio Therapeutics(ELTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Elicio Therapeutics(ELTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Elicio Therapeutics,ELTX,Elicio Therapeutics股票,Elicio Therapeutics股票老虎,Elicio Therapeutics股票老虎国际,Elicio Therapeutics行情,Elicio Therapeutics股票行情,Elicio Therapeutics股价,Elicio Therapeutics股市,Elicio Therapeutics股票价格,Elicio Therapeutics股票交易,Elicio Therapeutics股票购买,Elicio Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Elicio Therapeutics(ELTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Elicio Therapeutics(ELTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction